Dhiraj Kumar Selected Research

Intercellular Signaling Peptides and Proteins (Growth Factors)

1/2018	Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges.
8/2014	Osteopontin as a therapeutic target for cancer.
9/2011	Osteopontin: a potentially important therapeutic target in cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dhiraj Kumar Research Topics

Disease

37	Neoplasms (Cancer) 03/2024 - 09/2011
14	Infections 01/2023 - 09/2011
11	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2013
10	Breast Neoplasms (Breast Cancer) 01/2024 - 08/2014
8	Tuberculosis (Tuberculoses) 12/2023 - 11/2011
6	Visceral Leishmaniasis (Kala Azar) 05/2024 - 08/2006
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2016
6	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2015
4	Melanoma (Melanoma, Malignant) 10/2023 - 01/2013
3	Leishmaniasis 05/2024 - 08/2006
3	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 03/2024 - 01/2020
3	Carcinoma (Carcinomatosis) 11/2023 - 12/2018
3	Ovarian Neoplasms (Ovarian Cancer) 05/2023 - 11/2017
3	Nervous System Diseases (Neurological Disorders) 01/2022 - 11/2014
2	Multiple Myeloma 02/2024 - 10/2023
2	Glioma (Gliomas) 01/2023 - 01/2023
2	Proteostasis Deficiencies 01/2023 - 01/2019
2	Triple Negative Breast Neoplasms 01/2023 - 01/2018
2	COVID-19 02/2022 - 01/2021
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2016
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2020 - 01/2016
2	Huntington Disease (Huntington's Disease) 01/2020 - 01/2016
2	Multiple Sclerosis 01/2020 - 01/2016
2	Hypoxia (Hypoxemia) 01/2018 - 08/2014
2	Insulin Resistance 01/2017 - 01/2015
2	Channelopathies 01/2016 - 11/2014
2	Body Weight (Weight, Body) 01/2016 - 08/2014
1	Platypnea Orthodeoxia Syndrome 02/2024
1	Cardiogenic Shock 01/2024
1	Microsatellite Instability 10/2023
1	Polyps 02/2023

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2011
10	Peptides (Polypeptides)IBA 02/2024 - 03/2015
7	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2018
5	AntimonyIBA 05/2024 - 08/2006
5	InterferonsIBA 03/2024 - 01/2021
5	GoldIBA 05/2023 - 09/2016
5	CytokinesIBA 01/2020 - 09/2011
4	B7-H1 AntigenIBA 10/2023 - 01/2017
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2014
4	OsteopontinIBA 01/2021 - 09/2011
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2019
3	Phosphotransferases (Kinase)IBA 02/2023 - 01/2018
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 10/2016
3	AntibodiesIBA 01/2023 - 08/2014
3	Transcription Factors (Transcription Factor)IBA 03/2022 - 09/2011
3	ChemokinesIBA 01/2021 - 01/2013
3	Amyloid (Amyloid Fibrils)IBA 01/2019 - 01/2015
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 09/2011
3	SodiumIBA 11/2014 - 07/2010
2	LigandsIBA 03/2024 - 01/2019
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2024 - 01/2021
2	IntegrinsIBA 11/2023 - 01/2021
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 05/2023 - 01/2023
2	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2023
2	durvalumabIBA 01/2023 - 01/2021
2	Contrast MediaIBA 01/2023 - 09/2016
2	avelumabIBA 01/2023 - 01/2021
2	Adenosine Monophosphate (AMP)IBA 04/2022 - 01/2022
2	Antimicrobial PeptidesIBA 04/2022 - 01/2022
2	LipidsIBA 01/2022 - 04/2017
2	IronIBA 10/2021 - 12/2020
2	Monoclonal AntibodiesIBA 01/2021 - 01/2018
2	Oxidoreductases (Dehydrogenase)IBA 01/2021 - 11/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2017
2	Mitochondrial DNA (mtDNA)IBA 01/2020 - 01/2017
2	CholesterolIBA 11/2018 - 04/2017
2	Immune Checkpoint ProteinsIBA 01/2018 - 01/2017
2	LuteolinIBA 01/2018 - 09/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2016 - 08/2014
2	ProteomeIBA 07/2016 - 07/2012
2	Ion Channels (Ion Channel)IBA 01/2016 - 11/2014
2	gluconic acid (gluconate)FDA LinkGeneric 11/2013 - 07/2010
1	miltefosine (Impavido)IBA 05/2024
1	Gallium-68IBA 02/2024
1	Long Noncoding RNAIBA 01/2024
1	NexusIBA 01/2024
1	NucleotidesIBA 01/2024
1	Mediator ComplexIBA 11/2023
1	VimentinIBA 11/2023
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 02/2023
1	galleinIBA 02/2023
1	Phosphates (Orthophosphate)IBA 02/2023
1	FluoridesIBA 02/2023
1	PolyphosphatesIBA 02/2023
1	Chloroform (Trichloromethane)IBA 02/2023
1	Phenol (Carbolic Acid)FDA Link 02/2023
1	MineralsIBA 02/2023
1	Firefly LuciferasesIBA 01/2023
1	LuciferasesIBA 01/2023
1	StrontiumIBA 04/2022
1	Interleukin-6 (Interleukin 6)IBA 03/2022
1	Conditioned Culture MediaIBA 03/2022

Therapy/Procedure

33	Therapeutics 02/2024 - 09/2011
6	Immunotherapy 10/2023 - 05/2017
3	Radiotherapy 01/2018 - 12/2016
3	Drug Therapy (Chemotherapy) 01/2017 - 09/2011
2	Duration of Therapy 03/2016 - 03/2010
1	Microbubbles 02/2024
1	Length of Stay 01/2024